CD73+ CD127high Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 Infection
Authors:
- Nabila SeddikiNabila Seddiki
- John ZaundersJohn Zaunders
- Chan PhetsouphanhChan Phetsouphanh
- Vedran BrezarVedran Brezar
- Yin XuYin Xu
- Helen M. McGuireHelen M. McGuire
- Michelle BaileyMichelle Bailey
- Kristin McBrideKristin McBride
- Will Hey-CunninghamWill Hey-Cunningham
- Cynthia Mee Ling MunierCynthia Mee Ling Munier
- Laura CookLaura Cook
- Stephen KentStephen Kent
Open Access
- 18 January 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (2) , 912
Abstract
HIV-1 infection rapidly leads to a loss of the proliferative response of memory CD4+ T lymphocytes, when cultured with recall antigens. We report here that CD73 expression defines a subset of resting memory CD4+ T cells in peripheral blood, which highly express the α-chain of the IL-7 receptor (CD127), but not CD38 or Ki-67, yet are highly proliferative in response to mitogen and recall antigens, and to IL-7, in vitro. These cells also preferentially express CCR5 and produce IL-2. We reasoned that CD73+ memory CD4+ T cells decrease very early in HIV-1 infection. Indeed, CD73+ memory CD4+ T cells comprised a median of 7.5% (interquartile range: 4.5–10.4%) of CD4+ T cells in peripheral blood from healthy adults, but were decreased in primary HIV-1 infection to a median of 3.7% (IQR: 2.6–6.4%; p = 0.002); and in chronic HIV-1 infection to 1.9% (IQR: 1.1–3%; p < 0.0001), and were not restored by antiretroviral therapy. Moreover, we found that a significant proportion of CD73+ memory CD4+ T cells were skewed to a gut-homing phenotype, expressing integrins α4 and β7, CXCR3, CCR6, CD161 and CD26. Accordingly, 20% of CD4+ T cells present in gut biopsies were CD73+. In HIV+ subjects, purified CD73+ resting memory CD4+ T cells in PBMC were infected with HIV-1 DNA, determined by real-time PCR, to the same level as for purified CD73-negative CD4+ T cells, both in untreated and treated subjects. Therefore, the proliferative CD73+ subset of memory CD4+ T cells is disproportionately reduced in HIV-1 infection, but, unexpectedly, their IL-7 dependent long-term resting phenotype suggests that residual infected cells in this subset may contribute significantly to the very long-lived HIV proviral DNA reservoir in treated subjects.Keywords
Funding Information
- National Health and Medical Research Council (1063422, 1052979, 1037298)
This publication has 69 references indexed in Scilit:
- Innate and Adaptive Immunity in Long-Term Non-Progression in HIV DiseaseFrontiers in Immunology, 2013
- CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel diseaseEuropean Journal of Immunology, 2012
- Cellular function and molecular structure of ecto-nucleotidasesPurinergic Signalling, 2012
- Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter StudyClinical Infectious Diseases, 2012
- Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+T Regulatory Cells Correlates with Progressive DiseaseJournal of Virology, 2011
- Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory PhenotypeAmerican Journal of Transplantation, 2010
- CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2008
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionJournal of Experimental Medicine, 2007
- Infection of CD127+(Interleukin-7 Receptor+) CD4+Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsJournal of Experimental Medicine, 2006